Document is current
Any future updates will be listed below
-
Authors
Hoertel, N
Franco, S
Wall, M M
Oquendo, M A
Kerridge, B T
Limosin, F
Blanco, C
- License Information
-
More Information
Article History
Received: 4 August 2014
Revised: 14 January 2015
Accepted: 20 January 2015
First Online: 18 May 2015
Competing interests
: Dr Oquendo receives royalties for the commercial use of the C-SSRS and her family owns stock in Bristol Myers Squibb. Dr Limosin is a member of the speakers/advisory boards for Janssen, Euthérapie, Lundbeck and Roche. Other authors report no conflicts of interest.
